Dr. Thibault Geoui
@thibaultgeoui.bsky.social
Exploring Data & AI 🤖 in Life Sciences 🧬 and Drug R&D💊, with a side of tech, gadgets, and pop culture -💡- All opinions are my own
Just released my latest podcast "Tech and Drugs" Episode 8 with Shionogi's VP of Commercial Operations, Anindita (Ani) Sinha - join to learn How to build a Data-Driven Pharma organization through analytics & AI:P youtu.be/iXeEbTSdbbQ?...
Building a Data-Driven Pharma Organization Through Analytics & AI with Anindita “Ani” Sinha
YouTube video by Tech and Drugs - Podcast
youtu.be
June 3, 2025 at 11:21 AM
Just released my latest podcast "Tech and Drugs" Episode 8 with Shionogi's VP of Commercial Operations, Anindita (Ani) Sinha - join to learn How to build a Data-Driven Pharma organization through analytics & AI:P youtu.be/iXeEbTSdbbQ?...
Latest episode of "Tech and Drugs" Podcast is coming next week - here is the teaser: youtu.be/7q7cCSJ922g
Building a Data-Driven Pharma Organization Through Analytics & AI with Anindita “Ani” Sinha, TEASER
YouTube video by Tech and Drugs - Podcast
youtu.be
May 30, 2025 at 7:53 AM
Latest episode of "Tech and Drugs" Podcast is coming next week - here is the teaser: youtu.be/7q7cCSJ922g
Pharma's digital transformation isn't like waiting for a caterpillar to turn into a butterfly, it's like rebuilding the busiest city during rush hours
www.linkedin.com/pulse/pharma...
www.linkedin.com/pulse/pharma...
Pharma's digital transformation isn't like waiting for a caterpillar to turn into a butterfly, it's like rebuilding the busiest city during rush hours
Imagine stepping into a state-of-the-art pharmaceutical lab where every critical detail is meticulously captured: temperature, humidity, weight, and hundreds of other parameters essential for reproduc...
www.linkedin.com
May 20, 2025 at 8:46 AM
Pharma's digital transformation isn't like waiting for a caterpillar to turn into a butterfly, it's like rebuilding the busiest city during rush hours
www.linkedin.com/pulse/pharma...
www.linkedin.com/pulse/pharma...
"FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline" feels a bit rushed, isn't it?
"I was blown away by the success of our first AI-assisted scientific review pilot" said Dr. Makary.
Call me old school, but sounds strange in a PR!
"I was blown away by the success of our first AI-assisted scientific review pilot" said Dr. Makary.
Call me old school, but sounds strange in a PR!
May 8, 2025 at 5:19 PM
"FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline" feels a bit rushed, isn't it?
"I was blown away by the success of our first AI-assisted scientific review pilot" said Dr. Makary.
Call me old school, but sounds strange in a PR!
"I was blown away by the success of our first AI-assisted scientific review pilot" said Dr. Makary.
Call me old school, but sounds strange in a PR!
Why don't AI Agent already deliver at "production scale"? Perhaps we need to give them some time to mature ...
www.linkedin.com/posts/thibau...
www.linkedin.com/posts/thibau...
May 2, 2025 at 9:11 AM
Why don't AI Agent already deliver at "production scale"? Perhaps we need to give them some time to mature ...
www.linkedin.com/posts/thibau...
www.linkedin.com/posts/thibau...
Kicking the tires on #Futurehouse, the AI agent for discovery, and wow 🤯! Asked about replacing animal tests with NAMs—got back: Transition may feel "as challenging as convincing a cat to take a bath ", but step‑wise NAM adoption + tight regs + global sync = safer, faster, more ethical drug R&D.
May 2, 2025 at 4:45 AM
Kicking the tires on #Futurehouse, the AI agent for discovery, and wow 🤯! Asked about replacing animal tests with NAMs—got back: Transition may feel "as challenging as convincing a cat to take a bath ", but step‑wise NAM adoption + tight regs + global sync = safer, faster, more ethical drug R&D.
NAMs are reshaping drug R&D: rganoids, chips, in silico models, even microdosing.
But is this the full list? Are we missing emerging tools that defy categories?
As science moves fast, so must our definitions.
What would you add? #DrugDiscovery #NAMs #Toxicology
But is this the full list? Are we missing emerging tools that defy categories?
As science moves fast, so must our definitions.
What would you add? #DrugDiscovery #NAMs #Toxicology
May 1, 2025 at 8:28 AM
NAMs are reshaping drug R&D: rganoids, chips, in silico models, even microdosing.
But is this the full list? Are we missing emerging tools that defy categories?
As science moves fast, so must our definitions.
What would you add? #DrugDiscovery #NAMs #Toxicology
But is this the full list? Are we missing emerging tools that defy categories?
As science moves fast, so must our definitions.
What would you add? #DrugDiscovery #NAMs #Toxicology
#NAMs (New Approach Methodologies) are promising, but they still fall short in replicating the full complexity of living systems. Think organ-organ crosstalk, long-term effects, and chronic exposures. Biology isn’t a Petri dish… yet.
With more research, we just might get there. 🧬
With more research, we just might get there. 🧬
May 1, 2025 at 8:23 AM
#NAMs (New Approach Methodologies) are promising, but they still fall short in replicating the full complexity of living systems. Think organ-organ crosstalk, long-term effects, and chronic exposures. Biology isn’t a Petri dish… yet.
With more research, we just might get there. 🧬
With more research, we just might get there. 🧬
NIH to prioritize human-based research, echoing FDA’s phase-out of animal testing.
Great move, esp. from a basic research funder.
But shouldn’t this have come before we declared animal-free drug R&D?
#NIH #FDA #DrugDiscovery #TranslationalScience
Great move, esp. from a basic research funder.
But shouldn’t this have come before we declared animal-free drug R&D?
#NIH #FDA #DrugDiscovery #TranslationalScience
April 30, 2025 at 7:07 AM
NIH to prioritize human-based research, echoing FDA’s phase-out of animal testing.
Great move, esp. from a basic research funder.
But shouldn’t this have come before we declared animal-free drug R&D?
#NIH #FDA #DrugDiscovery #TranslationalScience
Great move, esp. from a basic research funder.
But shouldn’t this have come before we declared animal-free drug R&D?
#NIH #FDA #DrugDiscovery #TranslationalScience
Using AI in Scientific 🧬 Writing✍? Here’s Why Disclosure Misses the Point
www.linkedin.com/posts/thibau...
www.linkedin.com/posts/thibau...
Using AI in Scientific 🧬 Writing✍? Here’s Why Disclosure Misses the Point… | 🤖 🧠 Thibault GEOUI 🧬 💊
Using AI in Scientific 🧬 Writing✍? Here’s Why Disclosure Misses the Point
I recently found myself in the middle of debate while working on a scientific paper. One co-author said: "I rewrote ever...
www.linkedin.com
April 25, 2025 at 7:35 AM
Using AI in Scientific 🧬 Writing✍? Here’s Why Disclosure Misses the Point
www.linkedin.com/posts/thibau...
www.linkedin.com/posts/thibau...
Not all heroes wear capes: some wear lab coats and goggles - "Science: Fighting fake news and obscurantism, one data point at a time."
April 21, 2025 at 11:55 AM
Not all heroes wear capes: some wear lab coats and goggles - "Science: Fighting fake news and obscurantism, one data point at a time."
Reposted by Dr. Thibault Geoui
Richard Dawkins most famous reply to: "What if you're wrong?"
April 20, 2025 at 1:01 PM
Richard Dawkins most famous reply to: "What if you're wrong?"
The End of Animal Testing: Pharma’s Once-in-a-Lifetime Chance to Finally Fix Its Data
www.linkedin.com/pulse/end-an...
www.linkedin.com/pulse/end-an...
The End of Animal Testing: Pharma’s Once-in-a-Lifetime Chance to Finally Fix Its Data
On April 10, 2025, the FDA announced it would no longer require animal testing for monoclonal antibodies and other biologics. While this is a historic win for animal welfare, it’s also a signal of som...
www.linkedin.com
April 15, 2025 at 4:08 PM
The End of Animal Testing: Pharma’s Once-in-a-Lifetime Chance to Finally Fix Its Data
www.linkedin.com/pulse/end-an...
www.linkedin.com/pulse/end-an...
Life as a cat 🐈 is soooo stressful 😬
February 4, 2025 at 5:29 PM
Life as a cat 🐈 is soooo stressful 😬
it's great to improve government efficiency - but walking back on the mandate for the FDA to increase diversity is just STUPID 😵💫! Bad for patients and for business - not everyone receiving a treatment 💊 is a white / middle aged / Caucasian Male !
February 1, 2025 at 5:18 PM
it's great to improve government efficiency - but walking back on the mandate for the FDA to increase diversity is just STUPID 😵💫! Bad for patients and for business - not everyone receiving a treatment 💊 is a white / middle aged / Caucasian Male !
DNA testing + Longitudinal testing = ❤️ - read my latest article on this topic: www.linkedin.com/pulse/why-ne...
Why Neko Health Should Acquire 23andMe: The Missing Link in Personalized Healthcare 🧬💡
This morning, I read Matthew Pech ’s sharp analysis on 23andMe’s existential crisis: a brilliant mission and groundbreaking science hamstrung by a broken business model. The company’s core problem? It...
www.linkedin.com
February 1, 2025 at 11:06 AM
DNA testing + Longitudinal testing = ❤️ - read my latest article on this topic: www.linkedin.com/pulse/why-ne...